Suppr超能文献

真实世界数据在规划入组标准和增强招募中的应用:临床试验转化倡议的建议。

Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative.

机构信息

Biostatistics Center and the Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.

Food and Drug Administration, Silver Spring, MD, USA.

出版信息

Ther Innov Regul Sci. 2021 May;55(3):545-552. doi: 10.1007/s43441-020-00248-7. Epub 2021 Jan 3.

Abstract

The growing availability of real-world data (RWD) creates opportunities for new evidence generation and improved efficiency across the research enterprise. To varying degrees, sponsors now regularly use RWD to make data-driven decisions about trial feasibility, based on assessment of eligibility criteria for planned clinical trials. Increasingly, RWD are being used to support targeted, timely, and personalized outreach to potential trial participants that may improve the efficiency and effectiveness of the recruitment process. This paper highlights recommendations and resources, including specific case studies, developed by the Clinical Trials Transformation Initiative (CTTI) for applying RWD to planning eligibility criteria and recruiting for clinical trials. Developed through a multi-stakeholder, consensus- and evidence-driven process, these actionable tools support researchers in (1) determining whether RWD are fit for purpose with respect to study planning and recruitment, (2) engaging cross-functional teams in the use of RWD for study planning and recruitment, and (3) understanding patient and site needs to develop successful and patient-centric approaches to RWD-supported recruitment. Future considerations for the use of RWD are explored, including ensuring full patient understanding of data use and developing global datasets.

摘要

真实世界数据(RWD)的日益普及为整个研究领域的新证据生成和提高效率创造了机会。在不同程度上,赞助商现在经常根据对计划临床试验的资格标准的评估,使用 RWD 来做出有关试验可行性的数据驱动决策。越来越多的 RWD 被用于支持针对潜在试验参与者的有针对性、及时和个性化的外展,这可能会提高招募过程的效率和效果。本文强调了临床研究转化倡议(CTTI)为将 RWD 应用于规划资格标准和招募临床试验而制定的建议和资源,包括具体案例研究。这些可操作的工具是通过多利益相关者、共识和循证驱动的过程开发的,它们支持研究人员:(1)确定 RWD 是否适合研究规划和招募目的;(2)让跨职能团队参与 RWD 在研究规划和招募中的使用;(3)了解患者和站点的需求,以制定成功的、以患者为中心的方法,以支持 RWD 支持的招募。还探讨了使用 RWD 的未来考虑因素,包括确保患者充分了解数据的使用和开发全球数据集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a5/8021522/777fe69078b7/43441_2020_248_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验